Univ. Mainz - Universitaetsmedizin der Johannes Gutenberg Universitaet Mainz-University Medical Center
Welcome,         Profile    Billing    Logout  
 8 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Loquai, Carmen
EBIN, NCT03235245 / 2017-002887-42: Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Active, not recruiting
2
271
Europe
Nivolumab + Ipilimumab, Encorafenib + Binimetinib
European Organisation for Research and Treatment of Cancer - EORTC
Unresectable Stage III Melanoma, Stage IV Melanoma
10/23
01/27
Faber, Jörg
HIT-HGG-2013, NCT03243461 / 2013-004187-56: International Cooperative Phase III Trial of the HIT-HGG Study Group

Recruiting
3
167
Europe
Temozolomide + Valproic Acid
University of Göttingen, Deutsche Kinderkrebsstiftung, Hannover Medical School
Glioblastoma WHO Grade IV, Diffuse Midline Glioma Histone 3 K27M WHO Grade IV, Anaplastic Astrocytoma WHO Grade III, Diffuse Intrinsic Pontine Glioma, Gliomatosis Cerebri
12/23
12/23
ALLTogether1, NCT04307576 / 2018-001795-38: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
3
6430
Europe, RoW
Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto
Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins
Leukemia, Acute Lymphoblastic
06/27
06/32
PersoMed-I, NCT04402073 / 2020-003063-26: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Active, not recruiting
2
20
Europe, RoW
Sonidegib, Cisplatin, Lomustine, Vincristine, radiotherapy
European Organisation for Research and Treatment of Cancer - EORTC, EORTC-BTG, Sunpharmaceuticals
Medulloblastoma
04/25
04/25
FORTEe, NCT05289739: Exercise Training in Childhood Cancer

Active, not recruiting
N/A
450
Europe
Exercise training
Johannes Gutenberg University Mainz, University Hospital Heidelberg, Centre Leon Berard, Oxford Brookes University, Fondazione Monza e Brianza per il Bambino e la sua Mamma (MBBM), European University of Madrid, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, University Medical Centre Ljubljana, Rigshospitalet, Denmark, German Sport University, Cologne, University Hospital, Essen
Pediatric Oncology
09/25
08/26
Ringel, Florian
NCT04738162 / 2014-005669-54: Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Recruiting
2
80
Europe
5-Aminolevulinic Acid Hydrochloride, Oral, Gliolan
Universität Münster, photonamic GmbH & Co. KG, medac GmbH
Brain Tumor, Pediatric
06/25
06/25
PersoMed-I, NCT04402073 / 2020-003063-26: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Active, not recruiting
2
20
Europe, RoW
Sonidegib, Cisplatin, Lomustine, Vincristine, radiotherapy
European Organisation for Research and Treatment of Cancer - EORTC, EORTC-BTG, Sunpharmaceuticals
Medulloblastoma
04/25
04/25
CAR2BRAIN, NCT03383978: Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma

Active, not recruiting
1
42
Europe
NK-92/5.28.z, Ezabenlimab
Johann Wolfgang Goethe University Hospital, DRK Blutspendedienst Baden-Württemberg-Hessen gGmbH, Georg-Speyer-Haus, LOEWE Center Frankfurt Cancer Institute, German Cancer Research Center
Glioblastoma
12/25
06/26
PRAEMIUM, NCT04819074: Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms

Recruiting
N/A
4000
Europe, US, RoW
Microsurgery
University of Zurich, Macquarie University, Australia, University of Melbourne, Kepler University Hospital, Medical University Innsbruck, General University Hospital, Prague, Universitätsklinikum Köln, University Hospital, Frankfurt, University Medical Center Mainz, University of Göttingen, University Hospital Dresden, Charite University, Berlin, Germany, Heinrich-Heine University, Duesseldorf, University of Roma La Sapienza, University of Padova, University of Florence, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, University of Messina, Universita di Verona, Uniuversity of Genua, Italy, Leiden University Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), UMC Utrecht, Burdenko Neurosurgery Institute, Sahlgrenska University Hospital, Sweden, University of Bern, Barrow Neurological Institute, Stanford University, Emory University, University of Wisconsin, Madison, University of California, San Francisco, University of Illinois at Chicago, Brigham and Women's Hospital, Mayo Clinic, University of California, Los Angeles, NorthShore University HealthSystem, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Aneurysm, Brain
01/22
10/22
SWITCH, NCT02258919: Decompressive Hemicraniectomy in Intracerebral Hemorrhage

Completed
N/A
201
Europe
Decompressive craniectomy (DC) and best medical treatment, Best medical treatment
Insel Gruppe AG, University Hospital Bern
Cerebral Hemorrhage
10/23
05/24

Download Options